Notably, high DPEP1 expression correlates with poor survival in glioblastoma patients across multiple cohorts (Supplementary Figure 9D), while CD34 expression showed no impact on patient survival (Supplementary Figure 9H). This evidence concerns the gene CD34 and glioblastoma.